Bryan Giraudo - 18 Jun 2024 Form 4 Insider Report for Gossamer Bio, Inc. (GOSS)

Role: COO/CFO
Signature: /s/ Jeff Boerneke, Attorney-in-Fact
Issuer symbol: GOSS
Transactions as of: 18 Jun 2024
Net transactions value: +$59,110
Form type: 4
Filing time: 20 Jun 2024, 20:21:38 UTC
Previous filing: 28 Mar 2024
Next filing: 06 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GOSS	Common Stock	Purchase	$59,110	+100,000	+26%	$0.5911	480,010	18 Jun 2024	By family trust	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person's purchase of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 6,430 shares, with the Reporting Person's sale of 6,430 shares of common stock at a price of $1.1556 per share on March 27, 2024. The reporting person has agreed to pay to the Issuer $3,653.10, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.

Content

The Reporting Person's purchase of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 6,430 shares, with the Reporting Person's sale of 6,430 shares of common stock at a price of $1.1556 per share on March 27, 2024. The reporting person has agreed to pay to the Issuer $3,653.10, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.